ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,837, issued on Nov. 25, was assigned to Insmed Inc. (Bridgewater, N.J.).
"Reversible DPP1 inhibitors and uses thereof" was invented by Adam J. Plaunt (Bridgewater, N.J.), Adrien Cerdan (Strasbourg, France), Paola Ciapetti (Strasbourg, France) and Bastien Goegan (Strasbourg, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts or deuterated forms thereof, wherein R0, L and R1 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) or pharmaceutically acceptable salt or deuterated form thereof, and methods of using ...